What is it about?
The pathogenesis of PCOS, which affects 5-15% of women of reproductive age, is still poorly understood and which characteristic might be considered essential for its diagnosis is still unknown. This study aimed to determine the significance and relationship between Anti-Mullerian Hormone (AMH) and other infertility hormones in the Polycystic Ovarian Syndrome (PCOS) diagnosis.
Featured Image
Why is it important?
he AMH levels were noticeably higher in PCOS patients compared to controls. The AMH could not accurately diagnose PCOS when used as an independent marker. The AMH levels did, however, have good diagnostic potential in combination with current Rotterdam criteria for PCOS diagnosis.
Perspectives
A standard cut-off for AMH in PCOS hasn't been established yet, nevertheless, because different studies have produced contrasting findings due to differences in sample populations, sample sizes and sample selection approaches. The AMH can be utilized to diagnose PCOS either on its own or as an addition to the current Rotterdam criteria. This study was conducted to detect the role and association of AMH and other infertility hormones in the diagnosis of PCOS because there have been very few studies of this kind reported in Iraq.
Dr. Mushtak T.S. Al-Ouqaili
University of Anbar
Read the Original
This page is a summary of: The Association of Anti-Mullerian Hormone and Infertility Hormonal Imbalance with Polycystic Ovarian Syndrome Among Iraqi Patients, Pakistan Journal of Biological Sciences, April 2023, Science Alert,
DOI: 10.3923/pjbs.2023.241.248.
You can read the full text:
Contributors
The following have contributed to this page
